Encompass Health Corporation $EHC Shares Acquired by Fuller & Thaler Asset Management Inc.

Key Points

• Fuller & Thaler Asset Management Inc. increased its holding in Encompass Health Corporation by 11.9%, acquiring an additional 163,400 shares, bringing its total ownership to 1,541,477 shares valued at approximately $156.1 million.
• Encompass Health reported strong quarterly earnings with an EPS of $1.40, exceeding analysts' expectations, and a revenue increase of 12% year-over-year amounting to $1.46 billion.
• The company announced an increase in its quarterly dividend to $0.19 per share, with the payout representing a dividend yield of 0.6% and a payout ratio of 13.31%.

Fuller & Thaler Asset Management Inc. grew its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 11.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,541,477 shares of the company's stock after acquiring an additional 163,400 shares during the quarter. Fuller & Thaler Asset Management Inc. owned about 1.53% of Encompass Health worth $156,121,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in EHC. Colonial Trust Co SC purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $29,000. Transce3nd LLC purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $40,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after acquiring an additional 367 shares in the last quarter. Arlington Trust Co LLC lifted its position in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares in the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $72,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Down 0.5%

NYSE:EHC traded down $0.67 on Friday, reaching $122.76. The company's stock had a trading volume of 798,000 shares, compared to its average volume of 817,211. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $124.67. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a market cap of $12.36 billion, a price-to-earnings ratio of 24.02, a price-to-earnings-growth ratio of 2.16 and a beta of 0.86. The stock has a 50 day moving average price of $116.34 and a 200 day moving average price of $110.12.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the business earned $1.11 earnings per share. The company's revenue for the quarter was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This is a boost from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's payout ratio is presently 13.31%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Royal Bank Of Canada raised their target price on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Barclays lifted their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. UBS Group lifted their price objective on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research report on Thursday, June 5th. Finally, Wall Street Zen downgraded Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to MarketBeat, Encompass Health presently has an average rating of "Buy" and an average target price of $134.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.